Jacqueline Gannon

ORCID: 0000-0003-0318-3503
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Organ Donation and Transplantation
  • Palliative Care and End-of-Life Issues
  • Renal Transplantation Outcomes and Treatments
  • Cardiovascular Syncope and Autonomic Disorders
  • Acute Lymphoblastic Leukemia research
  • Dental Radiography and Imaging
  • Facial Trauma and Fracture Management
  • Rheumatoid Arthritis Research and Therapies
  • Cardiovascular Health and Disease Prevention
  • Organ and Tissue Transplantation Research
  • Autoimmune and Inflammatory Disorders Research
  • Facial Nerve Paralysis Treatment and Research
  • Heart Rate Variability and Autonomic Control
  • Reproductive Health and Technologies

Yale University
2016-2021

St. James's Hospital
2019

University of Pennsylvania
2018

Northwestern University
2018

Abstract Aims Orthostatic hypotension is a recognized complication of diabetes, but studies examining prevalence in diabetes are limited. The aim this study was to ascertain the orthostatic and pattern BP response cohort people with aged ≥ 50 years, embedded within Irish Longitudinal Study Ageing . Methods defined as drop systolic blood pressure (SBP) 20 mmHg or diastolic (DBP) 10 at 30 s after standing. Diabetes by self‐report cross‐checked against HbA 1c medication records. Multilevel...

10.1111/dme.14187 article EN Diabetic Medicine 2019-11-26

<h3>Rationale & Objective</h3> Enhanced informed consent tools improve patient engagement. A novel visual aid measured potential donors' risk tolerance to postdonation kidney failure and assessed if the closeness of relationship intended recipient altered willingness accept risk. <h3>Study Design</h3> Cross-sectional analysis donor evaluations at time enrollment into a longitudinal mixed-methods study between November 2014 February 2016. <h3>Setting Participants</h3> Three US transplant...

10.1053/j.ajkd.2020.11.028 article EN cc-by-nc-nd American Journal of Kidney Diseases 2021-01-26

Co-prescription of folic acid in patients receiving low dose oral methotrexate is recommended because it reduces adverse events and prolongs the use (MTX). However, little known about how often new users are co-prescribed acid, what factors associated with its use. We aimed to determine prevalence, predictors of, persistence a population-based cohort MTX rheumatic diseases.Using national, administrative database seen through Veterans Health Administration (VHA) that included pharmacy...

10.1371/journal.pone.0168369 article EN public-domain PLoS ONE 2016-12-15
Coming Soon ...